Elizabeth Ruiz-Lancheros
Overview
Explore the profile of Elizabeth Ruiz-Lancheros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makarkov A, Golizeh M, Ruiz-Lancheros E, Gopal A, Costas-Cancelas I, Chierzi S, et al.
NPJ Vaccines
. 2019 May;
4:17.
PMID: 31123605
A growing body of evidence supports the importance of T cell responses to protect against severe influenza, promote viral clearance, and ensure long-term immunity. Plant-derived virus-like particle (VLP) vaccines bearing...
2.
Ruiz-Lancheros E, Golizeh M, Ndao M
Methods Mol Biol
. 2019 Mar;
1955:263-273.
PMID: 30868534
Chagas disease (CD), endemic from Latin America, affects more than 8 million people, and the disease keeps spreading around the world due to population migrations. The treatment options for CD...
3.
Ruiz-Lancheros E, Rasoolizadeh A, Chatelain E, Garcia-Bournissen F, Moroni S, Moscatelli G, et al.
Open Forum Infect Dis
. 2018 Nov;
5(11):ofy236.
PMID: 30397621
Background: No reliable tests or validated biomarkers exist to ensure parasitological cure following treatment of Chagas disease (CD) patients chronically infected with . As seroreversion, the only marker of cure,...
4.
Ruiz-Lancheros E, Viau C, Walter T, Francis A, Geary T
Int J Parasitol
. 2011 Jan;
41(3-4):455-61.
PMID: 21195075
The free-living nematode Caenorhabditis elegans is a useful model for studying the pharmacology of anthelmintics. Currently approved anthelmintics have various mechanisms of action, including activity at nematode nicotinic acetylcholine receptors...